Free Trial

Elevance Health (ELV) Earnings Date, Estimates & Call Transcripts

Elevance Health logo
$401.45 +3.97 (+1.00%)
(As of 10:25 AM ET)

Elevance Health Latest Earnings Summary

Upcoming Q4
Earnings Date
Jan. 22Estimated
Actual EPS
(Oct. 17)
$8.37 Missed By -$1.29
Consensus EPS
(Oct. 17)
$9.66

Elevance Health issued Q3 2024 earnings on October 17, 2024, reporting an EPS of $8.37, which missed analysts' consensus estimates of $9.66 by $1.29. Quarterly revenue rose 5.3% year-over-year to $44.72 billion, above analyst estimates of $43.47 billion. With a trailing EPS of $27.43 and a P/E Ratio of 14.64, Elevance Health's earnings are expected to grow 7.25% next year, from $32.96 to $35.35 per share.

ELV Upcoming Earnings

Elevance Health's next earnings date is estimated for Wednesday, January 22, 2025, based off prior year's reporting schedules.

Get Elevance Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevance Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ELV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elevance Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$10.47$10.87$10.62 
Q2 20243$9.91$10.32$10.15 
Q3 20243$9.59$10.04$9.79 
Q4 20245$3.88$7.19$6.30 
FY 202414$33.85$38.42$36.86 
Q1 20252$10.35$11.71$11.03 
Q2 20253$8.94$11.43$10.52 
Q3 20252$9.66$11.25$10.46 
Q4 20253$5.68$7.83$6.99 
FY 202510$34.63$42.22$39.00 
Q1 20261$12.72$12.72$12.72 

Elevance Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
1/22/2025
(Estimated)
------- 
10/17/2024Q3 2024$9.66$8.37 -$1.29$12.38$43.47B$44.72B          
7/17/2024Q2 2024$9.99$10.12+$0.13$10.39$42.99B$43.22B          
4/18/2024Q1 2024$10.54$10.64+$0.10$11.69$42.49B$42.27B          
1/24/2024Q4 2023$5.60$5.62+$0.02$7.61$42.19B$42.45B        
10/18/2023Q3 2023$8.45$8.99+$0.54$12.53$42.69B$42.48B        
7/19/2023Q2 2023$8.78$9.04+$0.26$10.29$41.64B$43.38B        
4/19/2023Q1 2023$9.26$9.46+$0.20$10.62$40.93B$41.90B        
1/25/2023Q4 2022$5.20$5.23+$0.03$6.53$39.62B$39.67B      

Elevance Health Earnings - Frequently Asked Questions

Elevance Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 22nd, 2025 based off last year's report dates. Learn more on ELV's earnings history.

Elevance Health updated its FY24 earnings guidance on Thursday, October, 17th. The company provided EPS guidance of ~$33.00 for the period, compared to the consensus EPS estimate of $37.25.

In the previous quarter, Elevance Health (NYSE:ELV) missed the analysts' consensus estimate of $9.66 by $1.29 with a reported earnings per share (EPS) of $8.37. Learn more on analysts' earnings estimate vs. ELV's actual earnings.

The conference call for Elevance Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Elevance Health's latest earnings report can be read online.
Read Transcript

Elevance Health's earnings report can be found in their filing with the SEC.
View SEC filing

Elevance Health (NYSE:ELV) has a recorded annual revenue of $171.34 billion.

Elevance Health (NYSE:ELV) has a recorded net income of $5.99 billion. ELV has generated $27.43 earnings per share over the last four quarters.

Elevance Health (NYSE:ELV) has a trailing price-to-earnings ratio of 14.49 and a forward price-to-earnings ratio of 12.06. The price/earnings-to-growth ratio is 1.19.

Elevance Health's earnings are expected to grow from $32.96 per share to $35.66 per share in the next year, which is a 8.19% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:ELV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners